Capstone Investment Advisors
AMPH icon

Capstone Investment Advisors’s Amphastar Pharmaceuticals AMPH Stock Holding History

Capstone Investment Advisors’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-7,944
Closed -$318K – 1898
2024
Q2 		$318K Buy
+7,944
New +$329K ﹤0.01% 1563
2016
Q4 		– Sell
-14,200
Closed -$269K – 903
2016
Q3 		$269K Buy
+14,200
New +$258K 0.01% 632

Other funds holding AMPH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
EIP
Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Capstone Investment Advisors's AMPH Position: Q3 2024 in Review

Capstone Investment Advisors sold out of Amphastar Pharmaceuticals (AMPH) in Q3 2024, closing a stake of 7,944 shares — an estimated $318K sold.

Capstone Investment Advisors first reported a position in AMPH in Q3 2016 and held it in 2 quarters. The position peaked at $318K in Q2 2024. 279 funds tracked by Wall St. Rank hold AMPH as of Q3 2024.

  • Capstone Investment Advisors reported no remaining Amphastar Pharmaceuticals position as of Q3 2024 after selling out during the quarter.
  • Capstone Investment Advisors sold 7,944 Amphastar Pharmaceuticals shares in Q3 2024, an estimated $318K.
  • Capstone Investment Advisors first reported a position in Amphastar Pharmaceuticals in Q3 2016 and held it in 2 quarters.
  • Capstone Investment Advisors's Amphastar Pharmaceuticals position peaked at $318K in Q2 2024.
  • 279 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q3 2024.

Based on Capstone Investment Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.